Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin

Gespeichert in:

Bibliographische Detailangaben
Zeitschriftentitel:	Antimicrobial Agents and Chemotherapy
Personen und Körperschaften:	Aronoff, S C, Jacobs, M R, Johenning, S, Yamabe, S
In:	Antimicrobial Agents and Chemotherapy, 26, 1984, 4, S. 580-582
Format:	E-Article
Sprache:	Englisch
veröffentlicht:	American Society for Microbiology
Schlagwörter:	Infectious Diseases Pharmacology (medical) Pharmacology

Details
Zusammenfassung:	<jats:p>YTR 830, a new beta-lactamase inhibitor, was compared with clavulanic acid and sulbactam against aminopenicillin-resistant clinical isolates. At a concentration of 8 micrograms/ml, YTR 830 was as effective as clavulanate or sulbactam in reducing the aminopenicillin MICs. Combined with amoxicillin, YTR 830 is a potentially useful agent for therapy of many bacterial infections.</jats:p>
Umfang:	580-582
ISSN:	0066-4804 1098-6596
DOI:	10.1128/aac.26.4.580